Arkolith/Insider Trading/ADPT/Form 4

Rubinstein Julie

President and COOAdaptive Biotechnologies Corp (ADPT) · full profile →Form 4 · filed Apr 29, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$271K
Net Open-Market Flow
-$271K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 27, 2026Option exercise(M)15K$8.46$124K397K
Apr 27, 2026Sell(S)19K$14.23$271K378K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 27, 2026Option exercise(M)15K—$046K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001780664-26-000032) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML